Geneva, Switzerland

Sylvie Ferrari-Lacraz

This inventor holds 2 USPTO granted patents. Top assignee: Beth Israel Deaconess Medical Center, Inc.. Active years: 2004-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sylvie Ferrari-Lacraz. Retrieved from https://idiyas.com/inventor/sylvie-ferrari-lacraz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 51(Granted Patents)


Company Filing History:


Years Active: 2004-2008

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Sylvie Ferrari-Lacraz: Innovator in Immune Suppression

Introduction

Sylvie Ferrari-Lacraz is a prominent inventor based in Geneva, Switzerland. She has made significant contributions to the field of immunology, particularly in developing therapeutic compositions that modulate the immune response. With a total of two patents to her name, her work is paving the way for advancements in immune suppression therapies.

Latest Patents

Ferrari-Lacraz's latest patents focus on compositions and methods for achieving immune suppression. These patents disclose therapeutic compositions containing agents that effectively modulate the immune response in patients. Her innovative approach aims to provide new solutions for individuals requiring immune system regulation.

Career Highlights

Sylvie Ferrari-Lacraz is affiliated with the Beth Israel Deaconess Medical Center, Inc., where she continues her research and development efforts. Her work is characterized by a commitment to improving patient outcomes through scientific innovation.

Collaborations

Some of her notable coworkers include Terry Barton Strom and Wlodzimierz Maslinski. Their collaborative efforts contribute to the advancement of research in the field of immunology.

Conclusion

Sylvie Ferrari-Lacraz is a trailblazer in the realm of immune suppression, with her patents reflecting her dedication to advancing medical science. Her contributions are vital for the future of therapeutic interventions in immunology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…